Reduction in Dipyridamole-Induced Single-Photon Emission Computed Tomography Myocardial Defect Size by Beta-Blockers: Time to Re-Examine the Patient Preparation Protocol for Pharmacologic Stress Testing

Journal of the American College of Cardiology

Volumn 42, Issue 8, 2003, Pages 1484-1486

  Gerson, Myron C ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPYRIDAMOLE;

CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EDITORIAL; HEART DISEASE; HEART MUSCLE PERFUSION; HUMAN; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0142107353     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(03)01047-7     Document Type: Editorial

References (15)

1. Varma SK, Watson DD, Beller GA. Quantitative comparison of thallium-201 scintigraphy after exercise and dipyridamole in coronary artery disease. Am J Cardiol 1989;64:871-7.
2. Beller GA. Dipyridamole: thallium-201 scintigraphy: an excellent alternative to exercise scintigraphy. J Am Coll Cardiol 1989;14: 1642-4.
3. Sharir T, Rabinowitz B, Livschitz S, et al. Underestimation of extent and severity of coronary artery disease by dipyridamole stress thallium-201 single-photon emission computed tomographic myocardial perfusion imaging in patients taking antianginal drugs. J Am Coll Cardiol 1998;31:1540-6.
4. Taillefer R, Ahlberg AW, Masood Y, et al. Acute beta-blockade reduces the extent and severity of myocardial perfusion defects with dipyridamole Tc-99m sestamibi SPECT imaging. J Am Coll Cardiol 2003;42:1475-83.
5. Heusch G, Guth BD. Neurogenic regulation of coronary vasomotor tone. Eur Heart J 1989;10 Suppl F:6-14.
6. Billinger M, Seiler C, Fleisch M, Eberli FR, Meier B, Hess OM. Do beta-adrenergic blocking agents increase coronary flow reserve? J Am Coll Cardiol 2001;38:1866-71.
7. 1-adrenergic receptor blockade on myocardial blood flow and vasodilatory capacity. J Nucl Med 1997;38:442-6.
8. Beller GA, Holzgrefe HH, Watson DD. Effects of dipyridamole-induced vasodilation on myocardial uptake and clearance kinetics of thallium-201. Circulation 1983;68:1328-38.
9. Lattanzi F, Picano E, Bolognese L, et al. Inhibition of dipyridamole-induced ischemia by antianginal therapy in humans. Correlation with exercise electrocardiography. Circulation 1991;83:1256-62.
10. Kubota I, Ikeda K, Igarashi H, et al. Inhibition of dipyridamole-induced myocardial ischemia by diltiazem in patients with coronary artery disease. J Cardiovasc Pharmacol 1987;9:363-7.
11. Miller RR, Olson HG, Amsterdam EA, Mason DT. Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy. N Engl J Med 1975;293: 416-8.
12. Alderman EL, Coltart DJ, Wettach GE, Harrison DC. Coronary artery syndromes after sudden propranolol withdrawal. Ann Intern Med 1974;81:625-7.
13. Lindenfeld J, Crawford MH, O'Rourke RA, Levine SP, Montiel MM, Horwitz LD. Adrenergic responsiveness after abrupt propranolol withdrawal in normal subjects and in patients with angina pectoris. Circulation 1980;62:704-11.
14. Myers MG, Wisenberg G. Sudden withdrawal of propranolol in patients with angina pectoris. Chest 1977;71:24-6.
15. Knabb RM, Gidday JM, Ely SW, Rubio R, Berne RM. Effects of dipyridamole on myocardial adenosine and active hyperemia. Am J Physiol 1984;247:H804-10.